Related Experiment Videos

Predictors and outcomes associated with gastrointestinal bleeding in patients with acute coronary syndromes

Mouaz Al-Mallah1, Rasha N Bazari, Michelle Jankowski

  • 1Department of Internal Medicine, Henry Ford Hospital, Detroit, MI 48202, USA. monaz74@yahoo.com

Journal of Thrombosis and Thrombolysis
|December 23, 2006
PubMed

Insights

Gastrointestinal bleeding (GIB) complicates acute coronary syndromes (ACS) treatment, affecting 3% of patients. This serious complication significantly increases hospital mortality eightfold and requires further study for optimal management.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Internal Medicine

Background:

  • Acute coronary syndromes (ACS) treatments involve potent antiplatelet and anticoagulant agents, increasing gastrointestinal bleeding (GIB) risk.
  • GIB is a significant complication in ACS patients, but its predictors, management, and outcomes are understudied.

Purpose of the Study:

  • To investigate the incidence, predictors, pathological findings, and clinical outcomes of GIB in hospitalized ACS patients.
  • To identify risk factors associated with GIB in the ACS population.

Main Methods:

  • Retrospective analysis of ACS patients hospitalized between 1996 and 2001 at a US tertiary center.
  • Examined incidence, predictors, pathological findings, and clinical outcomes of GIB.

Main Results:

  • Clinically significant GIB occurred in 3% of ACS patients.
  • Predictors of GIB included older age, female gender, non-smoking status, elevated peak troponin I, and history of heart failure, diabetes, or hypertension.
  • GIB was associated with increased critical illness, need for transfusion/ventilation/pressors, and an eightfold increase in in-hospital mortality (36% vs. 5%).

Conclusions:

  • GIB in ACS patients is linked to specific demographic and clinical factors, including age, sex, troponin levels, and comorbidities.
  • Hospital mortality is substantially higher in ACS patients who experience GIB.
  • Further research is needed to determine the safety and optimal timing of endoscopic procedures in ACS patients with GIB.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...